NILOTINIB vs PAZOPANIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NILOTINIB vs PAZOPANIB: Safety Overview
| Metric | NILOTINIB | PAZOPANIB |
|---|---|---|
| Total FAERS Reports | 23,171 | 21,208 |
| Deaths Reported | 4,543 | 5,612 |
| Death Rate | 19.6% | 26.5% |
| Hospitalizations | 4,846 | 4,347 |
| Average Patient Age | 56.5 yrs | 61.2 yrs |
| % Female Patients | 47.7% | 41.2% |
| FDA Approval Date | Dec 15, 2025 | Apr 23, 2024 |
| Manufacturer | Novadoz Pharmaceuticals LLC | Golden State Medical Supply, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |